Barclays analyst Kannan Venkateshwar lowered the firm’s price target on Altice USA (ATUS) to $2 from $3 and keeps an Equal Weight rating on the shares. The firm says the company’s balance sheet constraints are forcing “sub optimal go-to-market choices,” which will continue to pressure EBITDA.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATUS: